How many insider trades does FilingIQ track for DNA?

FilingIQ tracks 1,028 Form 4 insider transactions for DNA (Ginkgo Bioworks Holdings, Inc.), covering filings from Sep 16, 2021 onwards. 39 of those were filed in the last 90 days.

Are DNA insiders net buyers or net sellers?

Across the full Form 4 history for DNA, 4 transactions (0%) were open-market purchases and 767 (75%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does DNA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is DNA in?

Ginkgo Bioworks Holdings, Inc. (DNA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $401.89M.

DNA insider trading

NYSE Healthcare

Ginkgo Bioworks Holdings, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

1,028

Last 90 days

Buys / sells

0% / 75%

Market cap

$401.89M

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Company website: www.ginkgo.bio

DNA insider activity at a glance

FilingIQ has scored 1,028 insider transactions for DNA since Sep 16, 2021. The most recent filing in our index is dated Apr 17, 2026.

Across the full history, 4 open-market purchases and 767 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on DNA insider trades is 48.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live DNA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding DNA

SB INVESTMENT ADVISERS (UK) LTD

$6.87M · 0.1% of AUM

Frequently asked

How many insider trades does FilingIQ track for DNA?: FilingIQ tracks 1,028 Form 4 insider transactions for DNA (Ginkgo Bioworks Holdings, Inc.), covering filings from Sep 16, 2021 onwards. 39 of those were filed in the last 90 days.
Are DNA insiders net buyers or net sellers?: Across the full Form 4 history for DNA, 4 transactions (0%) were open-market purchases and 767 (75%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DNA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is DNA in?: Ginkgo Bioworks Holdings, Inc. (DNA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $401.89M.

Methodology & sources

Every DNA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.